Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02724
Species: Homo sapiens
Position : chr12:2880430-3018116
Year: 2022
Title: A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: osteosarcoma
PMID:  35390165
MONDO: MONDO:0009807
Tissue: bone tissue
Tissue Ontology ID: UBERON:0002481
Cell Source: U2OS
CVCL ID: CVCL_0042
Cell Type: osteosarcoma cell
Experiment Type: Functional perturbation assay, Chromatin interaction assay, Enhancer activity assay
High Throughput Method: ChIP-seq; RNA-seq
Low Throughput Method: Luciferase Reporter Assay; ChIP-RT-qPCR; RT-RT-qPCR; Western blot, 3C; FISH; EMSA; FRAP
About Target Gene
Target gene : FOXM1
About TF
TF name : YY1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
YY1 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
YY1 DNA Damage Recognition in GG-NER reactome 38
YY1 E2F transcription factor network pid 77
YY1 mTOR signaling pathway pid 66
YY1 Notch-mediated HES/HEY network pid 48
YY1 Notch netpath 76
YY1 Notch signaling pathway pid 58
YY1 p53 pathway pid 59
YY1 Signaling events mediated by HDAC Class I pid 89
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_02721 chr12:2880430-3018116 uterine cervix malignant cell cervical cancer
E_02722 chr12:2880430-3018116 breast malignant cell breast carcinoma
E_02783 chr12:2880430-3018116 NA human embryonic kidney-derived cell line NA
Expression of Target Genes for the Enhancer